Advertisement

Topics

Phase 1 Trial Enrollment Initiated for Personalized Adoptive Cellular Therapy for Cancers

08:20 EDT 23 Aug 2017 | PharmPro

Immatics initiates personalized adoptive cellular therapy in patients with relapsed and/or refractory solid cancers using its pioneering target warehouse.
Contributed Author: 
Immatics

Original Article: Phase 1 Trial Enrollment Initiated for Personalized Adoptive Cellular Therapy for Cancers

NEXT ARTICLE

More From BioPortfolio on "Phase 1 Trial Enrollment Initiated for Personalized Adoptive Cellular Therapy for Cancers"

Advertisement
Quick Search
Advertisement
Advertisement